Daniel Barber | executive |
Ernie Toth | executive |
David Amsellem | analyst |
François Brisebois | analyst |
Raghuram Selvaraju | analyst |
Gary Nachman | analyst |
Stephen Wargacki | executive |
Thomas Flaten | analyst |
Good morning, and welcome to the Aquestive Therapeutics First Quarter 2024 Conference Call. [Operator Instructions] As a reminder, this call will be recorded.
I would now like to introduce your host for today's conference call, Bennett Watson of ICR Westwicke Investor Relations.
You may begin.
Thank you, operator.